2019
DOI: 10.1007/s12274-019-2549-7
|View full text |Cite
|
Sign up to set email alerts
|

Radioiodinated tyrosine based carbon dots with efficient renal clearance for single photon emission computed tomography of tumor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

4
5

Authors

Journals

citations
Cited by 16 publications
(5 citation statements)
references
References 34 publications
0
5
0
Order By: Relevance
“…131 I is a clinical used radioisotope with both diagnosis and therapy function. [ 12 ] The ZGCs could also serve as a nanoplatform to effectively deliver 131 I into tumor cells for enhanced RT. The combination of self‐generated ROS and RT demonstrated excellent tumor inhibition both in vitro and in vivo without the requirement of external light excitation.…”
Section: Introductionmentioning
confidence: 99%
“…131 I is a clinical used radioisotope with both diagnosis and therapy function. [ 12 ] The ZGCs could also serve as a nanoplatform to effectively deliver 131 I into tumor cells for enhanced RT. The combination of self‐generated ROS and RT demonstrated excellent tumor inhibition both in vitro and in vivo without the requirement of external light excitation.…”
Section: Introductionmentioning
confidence: 99%
“…The peaks at 2,920 and 2,850 cm −1 are attributed to the -CH 3 and -CH 2 symmetric stretching, respectively [38], which indicates that the surface of the CNDs contains a series of hydrocarbon groups [35]. Stretching vibrations of C=O, C-C, and C-O-C are localized at about 1,630, 1,460, and 1,150 cm −1 , respectively [39,40]. The FTIR spectrum of the CNDs reveals that they have abundant hydrocarbon chains, carboxyl and hydroxy functional groups on the surface of the CNDs.…”
Section: Characterization Of the Cndsmentioning
confidence: 98%
“…Carbon dots (CDs), with their unique optical properties, excellent stability, and biocompatibility, are promising for preclinical or potential clinical applications [85]. Most studies on carbon dots have focused on their optical imaging applications, which face challenges such as the low quantum yield of carbon dots and limited tissue penetration of light [86,87]. To overcome these hurdles, Liu et al developed 2.5 nm tyrosine-based carbon dots (TCDs) with phenolic hydroxyl groups on the surface for direct 125 I labeling.…”
Section: Nonmetallic Nanoparticlesmentioning
confidence: 99%